We conducted a phase IIIb-IV , multicenter , randomized , double-blind , active-controlled trial to compare IIV3-HD ( 60 g of hemagglutinin per strain ) with standard-dose trivalent , inactivated influenza vaccine ( IIV3-SD [ 15 g of hemagglutinin per strain ] ) in adults 65 years of age or older .